PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-52

  1. 1,664 Posts.
    lightbulb Created with Sketch. 177
    ”Then tell us what is going on behind the scenes”.
    Spot on Beaza! They/PR hide behind commercial
    confidentiality etc excuses, to keep us in the
    dark, as there is probably not much going on at
    all in the way of an imminent partnership or
    partnerships; and they want to keep the Marco
    fiasco under wraps.

    Mind you (and many will disagree with me as
    usual), I think it is still better to delay a
    partnership until we are in a better bargaining
    position, especially with OA, until we are
    further down the track towards NDA sub.

    In any case, it appears upfront MPS partnership
    payments would likely not be great enough
    to stave off a CR for long. IMO, we should
    just take dilution on the chin, as long as all
    shareholders are given the opportunity to
    participate. I know some here will say retail
    holders don’t deserve to take part in a CR,
    because there was not a substantial uptake
    last time. There is no reason why PAR cannot
    raise the required amount from existing large
    shareholders and instos and then on the same
    terms raise some extra scraps from
    retailers if it turns out that way. Even if we end
    up with SOI of circa 500M after regulatory
    approval, I don’t think that is outrageous, for
    such a potential blockbuster. Bloody hell, look
    at IMU as some on here rave about, as a
    comparison.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
-0.015(6.98%)
Mkt cap ! $70.04M
Open High Low Value Volume
21.0¢ 21.0¢ 20.0¢ $201.6K 994.6K

Buyers (Bids)

No. Vol. Price($)
15 429247 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 13806 2
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.